What Hims Really Costs for GLP-1 Treatment, Plan by Plan

What does Hims's GLP-1 program actually cost per month?

Land on the Hims weight-loss page and the price you see is the medication alone. The Wegovy Pill is advertised from $149 a month. What isn't obvious until later in the checkout flow is that every prescription also requires an active weight-loss membership, billed as its own separate charge. Stack the two together and the Wegovy Pill runs closer to $298 a month once the membership settles into its regular rate; the Wegovy Pen lands near $348; Zepbound climbs from about $448 to nearly $600 depending on dose.

That two-part structure is the single most important thing to understand before you sign up. The membership fee doesn't change based on which drug you're taking, and it doesn't pause if you skip a shipment. It renews on its own schedule. Knowing that upfront is what keeps the real bill from feeling like a surprise a month in.

The Hims membership fee — what $149 a month actually covers

New members pay $39 for the first month, then the membership renews at $149 a month going forward. That introductory rate is a genuine discount, not a marketing figure that vanishes at checkout — it mirrors the same structure sister brand Hers uses. It does not, however, include any medication. The membership is a separate subscription for access to the clinical side of the platform.

What that fee buys is ongoing access rather than a one-time visit: unlimited messaging with a licensed provider, a dedicated care team, monthly check-ins, and dosage adjustments as your treatment progresses, all handled asynchronously through the app. There's no separate consultation charge and no extra fee to ask a follow-up question. Over a full year, the membership alone — $39 for month one, then $149 for the remaining eleven — adds up to roughly $1,678, before a single dose of medication is factored in.

• Month 1 membership: $39
• Ongoing membership: $149/month
• Annual membership cost alone: ~$1,678
• Shipping: included, no extra charge for standard delivery
• Intake and prescriber review: included in the membership, no separate consult fee
• Injectable medications cannot ship to PO boxes due to temperature requirements for the shipment

Every Hims GLP-1 option and its real monthly price

Hims prescribes three brand-name GLP-1 medications, and none of them cost the same. Here's what each one runs on its own, before the membership is added back in.

Oral Wegovy (Wegovy Pill) — from ~$149/month medication

The Wegovy Pill is once-daily oral semaglutide — the same active drug as injectable Wegovy, in tablet form. It's currently the least expensive medication option Hims offers, priced from $149 a month for the starting dose. Paired with the ongoing $149 membership, that puts the all-in monthly total at roughly $298 once the introductory membership month has passed.

Injectable Wegovy (Wegovy Pen) — from ~$199/month medication

The Wegovy Pen is the original once-weekly semaglutide injection — the version behind the bulk of the published clinical data on the drug. Hims prices it from $199 a month for the medication. Combined with the membership, the starting all-in total lands near $348 a month. It's a step up from the pill in price, and it's the form most people picture when they think of Wegovy.

Zepbound (tirzepatide) — from ~$299/month, rising with dose

Zepbound is tirzepatide, available through Hims as either the KwikPen or the Vial. It's priced by dose rather than as a flat rate: the entry-level 2.5 mg starting dose runs from $299 a month, the 5 mg dose moves to roughly $399, and the higher maintenance doses (7.5 mg through 15 mg) run closer to $449. Add the membership, and Zepbound's all-in range spans from about $448 a month at the starting dose to nearly $600 a month at a higher maintenance dose. It's the most expensive of the three options, and also the one with the strongest average results in head-to-head trials against semaglutide — which is the trade-off driving most of the interest in it.

Can insurance or the Novo Nordisk savings card lower the price?

Two different discount paths exist, and they don't work the same way. The first is the standard Novo Nordisk Wegovy savings card, which can bring your medication copay down to as little as $25 a month — but only if you already have commercial insurance that covers Wegovy in some form. The card lowers your copay; it doesn't create coverage where none exists, and it explicitly excludes anyone on Medicare, Medicaid, or another government health program. Hims can help route a prescription toward this card, but the eligibility rules belong to Novo Nordisk, not to Hims.

The second path is newer: a multi-month prepay subscription Novo Nordisk introduced for self-pay Wegovy patients, no insurance required, where the price drops the longer you commit. It launched in spring 2026 through a handful of telehealth partners, with Hims named as a platform bringing it online. Whether it's fully live on the Hims platform at the moment you sign up is worth confirming directly with support before you count on it, since manufacturer rollouts to individual telehealth partners don't always land on the same day.

Hidden fees and billing details that catch people off guard

The dual-subscription structure is the most common source of billing confusion in Hims reviews. Membership and medication are two separate charges on two separate schedules, and cancelling one does nothing to the other. There is also no self-service cancel button inside the Hims account — ending a subscription requires contacting support directly, and multiple Trustpilot and BBB complaints describe charges or shipments continuing after a cancellation request was submitted.

Dose changes can also reprice your bill without much warning. Zepbound in particular is priced by dose tier, so titrating up from a starting dose to a maintenance dose can add real money to the monthly medication charge — confirm the price at your new dose before you agree to the increase.

The other shift worth knowing about: compounded semaglutide, which Hims sold heavily through 2024 and 2025 at a much lower price point, is no longer offered to new patients. Novo Nordisk sued Hims & Hers over patent and marketing issues in February 2026, and the companies settled the following month, with Hims agreeing to exit compounded semaglutide for new patients in favor of the brand-name partnership described above. That settlement followed an FDA warning letter to Hims over marketing language that implied its compounded product was equivalent to FDA-approved Wegovy — a letter issued the same day as a related one sent to sister brand Hers. If you're coming to Hims expecting the older, cheaper compounded pricing, that option is effectively gone.

What a full year of Hims GLP-1 treatment actually costs

Here's the annual math, assuming you stay on a starting dose for the year and take the first-month membership discount into account.

• Membership alone: ~$1,678/year
• Oral Wegovy (Wegovy Pill, starter dose): membership + medication = ~$3,466/year
• Injectable Wegovy (Wegovy Pen, starter dose): membership + medication = ~$4,066/year
• Zepbound at starting dose: membership + medication = ~$5,266/year
• Zepbound at a higher maintenance dose: membership + medication = ~$6,466 to $7,066/year
• With qualifying commercial insurance and the Novo Nordisk savings card: as low as ~$1,678/year, membership only

Most people titrate upward over the course of a year rather than staying on a starting dose the whole time, so the realistic number for anyone on Zepbound tends to land toward the higher end of that range rather than the lower one. Budget with that in mind rather than anchoring to the cheapest listed price.

How Hims pricing compares to Ro, Hers, and compounded alternatives

Hims isn't the only brand-name GLP-1 telehealth option, and it isn't the cheapest path to semaglutide or tirzepatide if cost is your primary filter. Here's how it stacks up against three providers women commonly compare it to.

• Hims (Wegovy Pill, starting dose): ~$298/month all-in — brand-name semaglutide, membership and medication billed separately
• Ro: $39 first month, then ~$145/month membership, plus medication priced separately — a near-identical dual-billing structure with its own brand-name GLP-1 lineup
• Hers: Hims's sister brand under the same parent company, with an essentially identical $39-then-$149 membership and matching Wegovy pricing — the main difference is which provider you'd rather work with, not the underlying cost
• Mochi Health: ~$178/month all-in ($79 membership + $99 compounded semaglutide, flat across doses) — a compounded option, not brand-name, at a meaningfully lower price

The real choice isn't just about the number. Hims, Ro, and Hers are all selling FDA-approved brand-name drugs that went through the agency's full review process. Mochi Health and similar compounded-only providers sell the same active molecule at a lower price, but compounded semaglutide is prepared by a pharmacy under a different regulatory pathway and hasn't been reviewed by the FDA for that specific product's safety, effectiveness, or manufacturing consistency. Which trade-off makes sense depends on your budget and your comfort with that distinction.

Is the Hims GLP-1 price worth it?

For a lot of people, yes — with the two-line-item structure factored in from the start. Hims made brand-name Wegovy and Zepbound accessible without a video visit, at a price meaningfully below retail pharmacy cost for anyone paying cash. The Wegovy Pill's all-in total of roughly $298 a month is a real discount against what that same drug costs at a pharmacy counter without insurance, and the async model means you can be prescribed and shipped medication within about a week of signing up.

The trade-offs are worth naming plainly rather than glossing over. The membership adds nearly $1,700 a year before you've paid for a single dose of medication, cancellation requires contacting support rather than a one-click toggle, and Zepbound's dose-based pricing means your bill can climb as treatment progresses. None of that makes Hims a bad option — it makes it one where reading the full pricing structure before you enroll saves you a surprise later.

Hims makes the most sense for someone who wants a brand-name, FDA-approved GLP-1 without a lot of clinical hand-holding, and who has checked whether the Novo Nordisk savings card applies to their insurance before assuming the lower price. It makes less sense for a tight monthly budget that would be better served by a compounded option like Mochi Health, or for anyone who wants GLP-1 treatment discussed alongside hormone therapy — Hims doesn't offer HRT, and its clinical team isn't built around menopausal care.

For the fuller picture of how Hims works day-to-day — the intake process, prescriber model, and where it fits for women specifically — the full Hims review covers that ground in depth.